A-ALPHA BIO
A-Alpha Bio provides cell-based tools for quantitative and high-throughput measurements of protein interactions, accelerating target discovery, library screening, and preclinical drug characterization. A-Alpha Bio's product, AlphaSeq, is a revolutionary cell-based platform technology that will fundamentally change the way that protein interactions are measured. A-Alpha Bio is a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck.
A-ALPHA BIO
Industry:
Biotechnology Health Care Product Design
Founded:
2017-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.aalphabio.com
Total Employee:
11+
Status:
Active
Contact:
8584057116
Email Addresses:
[email protected]
Total Funding:
24.45 M USD
Technology used in webpage:
Euro Wix Google Cloud Global Multi-Region Wix Hosted
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
EnBiotix
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Current Advisors List
Current Employees Featured
Founder
Investors List
Madrona Venture Group
Madrona Venture Group investment in Series A - A-Alpha Bio
Perceptive Advisors
Perceptive Advisors investment in Series A - A-Alpha Bio
Lux Capital
Lux Capital investment in Series A - A-Alpha Bio
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - A-Alpha Bio
National Science Foundation
National Science Foundation investment in Grant - A-Alpha Bio
Madrona Venture Group
Madrona Venture Group investment in Seed Round - A-Alpha Bio
Sahsen Ventures
Sahsen Ventures investment in Seed Round - A-Alpha Bio
AME Cloud Ventures
AME Cloud Ventures investment in Seed Round - A-Alpha Bio
Washington Research Foundation
Washington Research Foundation investment in Seed Round - A-Alpha Bio
Boom Capital
Boom Capital investment in Seed Round - A-Alpha Bio
Official Site Inspections
http://www.aalphabio.com
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "A-Alpha Bio"
About - A-Alpha Bio
A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions.See details»
A-Alpha Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 8584057116 A-Alpha Bio is a provider of cell-based tools for quantitative and high-throughput measurements of protein interactions, accelerating target discovery, library …See details»
A-Alpha Bio Company Profile 2024: Valuation, Funding …
Sep 13, 2019 Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20240309062-A1: Interferon alpha-2 variants: Pending: 16-Mar-2023: US-20240363194-A1See details»
A-Alpha Bio Awarded Additional $14.5M from the Department of …
A-Alpha's partnership with LLNL began with $1M in funding in 2022 and was expanded in 2023 with an additional $2.4M, with funding provided by JPEO-CBRND GUIDE.This collaboration is …See details»
A-Alpha Bio Company Overview, Contact Details & Competitors
May 21, 2024 [email protected]: 1%. See more formats. Frequently Asked Questions Where is A-Alpha Bio 's headquarters located? A-Alpha Bio 's main headquarters is …See details»
A-Alpha Bio Inc. - Devex
Learn more about A-Alpha Bio Inc.'s jobs, projects, latest news, contact information and geographical presence. "Accelerating drug development with synthetic biology and next …See details»
A-Alpha Bio, Inc. | VentureRadar
"A-Alpha Bio provides biologics and molecular glue discovery and optimization services to pharmaceutical companies that require binding and/or specificity optimization to multiple target …See details»
A-Alpha Bio Overview - Salary.com
Its mission is to empower every person and every organization on the planet to achieve more. A. Aria Systems, Inc Aria ... The official website of A-Alpha Bio: aalphabio.com. 3. What is the …See details»
Our Technology - A-Alpha Bio
The throughput and sensitivity of AlphaSeq makes the platform well suited to uncover novel targets for molecular glues by discovering and characterizing weak interactions between E3 ubiquitin ligases (or other effector proteins) and target …See details»
A-Alpha Bio, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for A-Alpha Bio, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
A-Alpha Bio - LinkedIn
A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions.See details»
A-Alpha Bio Awarded Additional $14.5M from the Department
May 21, 2024 Funding supports A-Alpha Bio’s continued partnership with Lawrence Livermore National Laboratory to generate large-scale antibody-antigen binding data and train …See details»
A-Alpha Bio, a biotech startup that measures and predicts
Jul 25, 2023 A-Alpha Bio is among a growing flock of startups using AI as a tool to help scientists forge proteins into drugs, industrial enzymes, biosensors, food products and more.. …See details»
A-Alpha Bio Raises $22.4M in Series A2 to Scale Protein-Protein ...
SEATTLE, July 25, 2023 /PRNewswire-PRWeb/ — A-Alpha Bio, a synthetic biology and machine learning (ML) company that measures and engineers protein-protein interactions, today …See details»
Careers - A-Alpha Bio
Join us on our mission to improve human health by unlocking the potential of protein-protein interactions. We are an interdisciplinary team of creative, action-oriented, and purpose-driven …See details»
A-Alpha Bio Announces Collaboration With Gilead to Advance …
Jun 13, 2023 A-Alpha Bio's AlphaSeq and AlphaBind platforms will measure millions of protein interactions and engineer cross-reactive and potent HIV therapeuticsSEATTLE, June 13, 2023 …See details»
Contact - A-Alpha Bio
Get in contact with A-Alpha Bio by using our form or by emailing usSee details»
News - A-Alpha Bio
Read up on A-Alpha Bio’s latest news and updatesSee details»
Pipeline - A-Alpha Bio
A-Alpha Bio is advancing a differentiated pipeline of cis-targeting immunocytokines, consisting of a detuned and stabilized cytokine fused to a targeting antibody.See details»